SITE-DIRECTED MODIFICATION OF FVIII

This invention relates to Factor VIII muteins that are covalently bound, at a predefined site that is not an N-terminal amine, to one or more biocompatible polymers such as polyethylene glycol. The mutein conjugates retain FVIII procoagulant activity and have improved pharmacokinetic properties. 本发明...

Full description

Saved in:
Bibliographic Details
Main Authors STRAUSS JONATHAN S, TJANDRA HENDRI, BARNETT THOMAS, MEI BAISONG, WANG DEQIAN, CHEN JLANMIN, MURPHY JOHN E, PAN CLARK Q, TANG LIANG
Format Patent
LanguageChinese
English
Published 13.07.2016
Subjects
Online AccessGet full text

Cover

Loading…